HOME
OUR FOCUS
OUR TEAM
NEWS
More
Bexson Biomedical Launches New Project, Applying Subcutaneous Delivery Technology To Multiple Psychedelic Compounds For Therapeutic Use
Labroots - Tweaked Version of Ketamine Could Solve the Opioid Crisis
Bexson Biomedical Granted USPTO Patent On Proprietary Ketamine Formulation
Bexson Biomedical Hires Veteran Medical Device Development Leader, Will Focus On New Dosing & Delivery Solutions For Controlled Substances
Bexson Biomedical Raises $4.8 Million In Oversubscribed Series A
Bold Business: Battling Opioid Addiction With Technology – Breakthroughs in Wearable Devices
Stevanato Group And Bexson Biomedical Announce Collaboration To Develop A Customized Wearable Ketamine Delivery Device
Forbes - This Wearable Ketamine Device Could be the Future of Pain Management
Bexson Biomedical To Co-Host Virtual Ketamine Conference
Bexson Biomedical Adds Industry Leaders Bill Carson And Noah Craft As Advisors
April 2021 -- Investor Presentation
